Québec Becomes First Province to Cover TRYNGOLZA® (olezarsen) for Familial Chylomicronemia Syndrome
Quebec is the first Canadian province to list TRYNGOLZA® (olezarsen) on the drug formulary of its public drug insurance plan.
Nos infolettres de juillet 2026 sont maintenant disponibles…
Our June 2026 newsletters are now available…
Our May 2026 newsletters are now available…
Our April 2026 newsletters are now available…
Our March 2026 newsletters are now available…
We are pleased to present the brand new February…
The BIOQuébec team is pleased to invite you to discover the …
A rich legacy for your association Dear members of the ecosystem, The past year has been one of action and…
As we approach the end of 2025, I would like to look back on the last few months, which have…
Quebec is the first Canadian province to list TRYNGOLZA® (olezarsen) on the drug formulary of its public drug insurance plan.
We use cookies to improve your browsing experience and analyze our traffic. By clicking "Accept", you consent to our use of cookies.
Privacy Policy